Sanhe PERFECTLASER Technology Co., Ltd. appears in FDA records as the applicant on two traditional 510(k) submissions, both received July 29, 2026 and both decided as substantially equivalent (SESE) in October 2026. The two devices share a product code, a regulation number and an advisory committee, which places them in the same regulatory category even though the laser technologies differ. The company's documented footprint in the supplied filings is limited to these two clearances; no recalls appear in the supplied record sample. [1][2][6]

The two cleared laser systems

The Fractional CO2 Laser Therapy System (Z121) was cleared under K262627 with a decision date of October 26, 2026. The Picosecond Laser treatment system (Z180) was cleared under K262628 with a decision date of October 20, 2026. Both are listed as class 2 devices under product code GEX, regulation 21 CFR 878.4810, with the classification name Powered Laser Surgical Instrument and a medical specialty of General, Plastic Surgery. [1][2][6]

The K262627 summary states that no clinical study is included in that submission and that the conclusion rests on non-clinical testing, comparing the subject device to a predicate Fractional CO2 Laser Therapy System cleared under K241670. The summary also references IEC 60601-1-2 Edition 4.1 electromagnetic compatibility testing and cytotoxicity testing among the non-clinical work described. [3]

Submission and review details

Both filings are recorded as Traditional 510(k)s, not third-party reviewed, with a Summary rather than a Statement. Both list the advisory committee as SU, described as General, Plastic Surgery. The K262627 record lists the applicant contact as Yongchao Lian and a Langfang, China address; the K262627 clearance letter is addressed care of Ray Wang, General Manager, Beijing Believe-Med Technology Service Co., Ltd., in Beijing. These are filing addresses, and the sources do not establish a headquarters location. [1][2][3]

Independent trackers index the same two records. FDA.report and Innolitics both list K262628 as a Picosecond Laser treatment system (Z180) from Sanhe PERFECTLASER Technology Co., Ltd. with a decision date of October 20, 2026, and Innolitics lists K262627 as the Fractional CO2 Laser Therapy System (Z121) with a decision date of October 26, 2026. [6][7][8]

What the collection counts mean

The supplied portfolio snapshot, retrieved November 20, 2026, contains two linked 510(k) records, both with a decision of SESE; the smaller record sample of two entries carries the same two SESE decisions. These figures describe the supplied filings only and are not a measure of total company sales, total portfolio or safety performance. No recall records appear in the supplied sample. [1][2]

A broader FDA listing of 510(k) final decisions rendered since October 1, 2026 shows the agency publishing many substantially equivalent decisions across unrelated device types and applicants during the same period, which places the two Sanhe PERFECTLASER clearances within routine CDRH output rather than a unique event. [4][5]

Context in the laser device category

A third-party tracker covering FDA product codes GEX and ONG reports 158 clearances and 13 recall records in that category since November 15, 2024, with its latest listed clearance dated November 5, 2026 and a page update of November 18, 2026. That tracker describes itself as an independent publication unaffiliated with any device manufacturer. Its category totals are not attributable to Sanhe PERFECTLASER. [9]

The same tracker notes that FDA publishes a clearance after the decision date, so the newest decisions can take several weeks to appear. The public documents do not document manufacturing sites, ownership, brand relationships, customers, pricing or commercial availability for Sanhe PERFECTLASER, and those points remain unknown. [9]